25.05.2010 • NewsBiofuelsDSM

Bio-based Economy Beckons, Says DSM

Photo by Jurvetson (flickr)
Photo by Jurvetson (flickr)

Shifting to a bio-based economy from fossil fuel-based is feasible but key steps are needed to make the transition work in a sustainable way, experts said at a briefing on Friday. Bio-based sources from agriculture could provide a signicant amount of fuel, power and chemicals in the future instead of carbon-heavy fossil fuels which will eventually run out.

"A bio-based economy is inevitable, it is needed for a sustainable future," said Rob Van Leen, chief innovation officer at Netherlands-based chemicals group DSM.

Currently, biomass represents 10% of power and heat generation and 4% of transport fuel, while bio-based energy is five times as big as wind power, according to consultants McKinsey and Company.

"The contribution of bio-energy in heat and power alone should more than double in the next 10 years based on current legislation," said Jan Riese, principal at McKinsey.

But a bio-based transition is fraught with challenges. Difficulties arise from sourcing low-cost biomass on a large scale, sustainable raw material use, developing new technology for clean fuel conversion, funding large-scale demonstration second generation bio-refineries and supportive global policies.

"There is a limit to how much biomass can be sustainably produced. We need to manage any transition very carefully," said Nadine McCormick for the Internation Union for the Conservation of Nature.

Currently, biofuels are the largest application of a bio-based economy but need to become more economically viable. They have been criticised for diverting agricultural production away from food crops and driving up fuel prices. I

Investment DSM

DSM has invested €60 million into biotechnology innovation. Industrial or "white" biotechnology speeds up the replacement of traditional chemical and fossil fuel processes and products. It is forecast to grow to a $150 billion business from $115 billion in the coming years, the OECD says.

DSM sees partnerships across sectors as an important way to speed up this growth.

"The pulp and paper sector has experienced reduced demand for newspapers but it has a tree supply infrastructure so is a likely candidate to work with to convert biomass into chemicals," said Volkert Claassen, DSM's head of white biotechnology.

Biorefinery development will also play an important role. Currently, second generation refineries are all in the experimental phase and their development will need long-term support from governments. A demonstration plant would cost around €100 million. Europe is lagging behind the U.S. in bio-based industry development, Claassen said.

"Europe has different leaders and no consistency. The EU is making a lot less money available (for demonstration plants) than the U.S.," he added.

Company

Royal DSM N.V.


6401 JH Heerlen

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.